Patient info Open main menu

L01EA BCR-ABL tyrosine kinase inhibitors

ATC group of level 4 – chemical subgroup · in plain English: targeted cancer medicines (kinase inhibitors)

This site has the patient leaflet or the SPC of 101 medicines in this group and its subgroups.

Place in the ATC classification

  1. L Antineoplastic and immunomodulating agents 1,791 medicines
    1. L01 Antineoplastic agents 1,025 medicines
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
        1. L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
          1. L01EA01 imatinib 22 medicines
          2. L01EA02 dasatinib 55 medicines
          3. L01EA03 nilotinib 8 medicines
          4. L01EA04 bosutinib 11 medicines
          5. L01EA05 ponatinib 5 medicines

Medicines in the group and its subgroups

MedicineLegal category
Uxil 79 mg film-coated tablets no longer supplied (L01EA02 dasatinib) –

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group L01EA

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.